Daniel Birnbaum, SodaStream CEO, Named Board Member at SeedoPosted on March 18, 2019
Recognized Global Brand Expansion Expert Makes Personal Investment in Israeli Vertical Farming and Home Growing Solution Company
Daniel Birnbaum, CEO of SodaStream, the world’s leader in at-home sparkling beverage preparation, has made a personal investment in and joined the board of directors at Seedo Corp., “Seedo” (OTCQB: SEDO), a high-tech company providing the world’s first fully automated and controlled indoor growing machine for pesticide-free agricultural and vertical farming markets. Daniel is widely recognized for transforming SodaStream from a struggling company into a multi-billion-dollar company, which was acquired by PepsiCo Inc. for $3.2 billion late last year. Previously, Daniel was the general manager of Nike Israel, a founding member of Nuvisio Corporation, a technology startup, and established Pillsbury Israel while serving as its CEO. Daniel’s proven success in growing businesses will be an asset for Seedo as the company navigates becoming a top global brand.
“I am excited about Seedo not only because of the medicinal and nutritional prospects behind high-quality hemp growth but even more so because of the possibilities Seedo is developing to help increase farming productivity around the globe,” said Seedo Board Member Daniel Birnbaum. “The team at Seedo is committed to helping make the world a better place and I look forward to being part of that important journey.”
Seedo’s airtight system is the world’s first fully automated and controlled indoor growing machine for home-grow and commercial hemp, herbs and vegetables to cost-effectively generate high yields of lab-grade, pesticide-free product. The Seedo solution minimizes cultivation costs by delivering maximum daylight illumination, built-in carbon filters, automated air conditioning, and a smart post-harvest drying system to users. Even in the harshest environments or with limited space, cultivators can use Seedo’s intelligent technology to harvest the next generation of precision agriculture. This software-driven technology will be extended to large-scale farming solutions, including vertical farming, where yields may be a significantly greater than traditional farming. Additionally, with the Seedo growing system, seasons and weather conditions will not impact growing patterns or yields.
“We’re honored to have Daniel Birnbaum join our mission to bring consistent high-quality agriculture products to the global home-grow and commercial markets,” said Seedo CEO Zohar Levy. “Daniel’s experience will surely be an important asset as Seedo seeks to develop and execute on its global growth strategy.”
Daniel’s appointment comes shortly after the announcement of Seedo’s partnership with SYS Technologies, an innovative indoor and portable clean environment company, to deploy advanced containerized clean growing solutions for commercial use. Seedo also recently delivered its first pre-sale home-grow units to customers in California in addition to qualifying for the OTCQB® Venture Market to streamline the stock procurement process for investors.
Seedo is a market leading high-tech company providing the hemp and agriculture industries with the world’s first fully automated and controlled indoor growing machine. Seedo provides growers with the freedom to cut costs while generating high yields of lab-grade, pesticide-free herbs and vegetables. Seedo’s AI-powered, turnkey systems enable anyone from average consumers to large-scale producers the ability to grow without prior experience or ample space. Seedo is a publicly traded company backed by a group of international investors including Cannabics Pharmaceuticals and is headquartered in Israel. For more information, visit http://www.seedolab.com
Certain statements contained in this release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to statements identified by words such as “believes,” “expects,” “anticipates,” “estimates,” “intends,” “plans,” “targets,” “projects” and similar expressions. The statements in this release are based upon the current beliefs and expectations of our company’s management and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements. Numerous factors could cause or contribute to such differences, including, but not limited to, results of clinical trials and/or other studies, the challenges inherent in new product development initiatives, the effect of any competitive products, our ability to license and protect our intellectual property, our ability to raise additional capital in the future that is necessary to maintain our business, changes in government policy and/or regulation, potential litigation by or against us, any governmental review of our products or practices, as well as other risks discussed from time to time in our filings with the Securities and Exchange Commission, including, without limitation, our latest Form 10-K Report filed on January 15th, 2019. We undertake no duty to update any forward-looking statement or any information contained in this press release or in other public disclosures at any time.